To investigate the basis of extended peptide reactivity by polyclonal T cells from diverse TRBV families, we isolated and expanded NY-ESO-160–72-HLA-B*07:02 reactive CD8+ T cells from peripheral blood mononuclear cells (PBMC) of patients with melanomas expressing NY-ESO-1. This evidence concerns the gene CD8A and melanoma.